Literature DB >> 25164083

Role of caveolin 1 in AT1a receptor-mediated uptake of angiotensin II in the proximal tubule of the kidney.

Xiao C Li1, Victor Gu1, Elise Miguel-Qin1, Jia L Zhuo2.   

Abstract

Caveolin 1 (CAV-1) functions not only as a constitutive scaffolding protein of caveolae but also as a vesicular transporter and signaling regulator. In the present study, we tested the hypothesis that CAV-1 knockout (CAV-1 KO) inhibits ANG II type 1 [AT1 (AT1a)] receptor-mediated uptake of ANG II in the proximal tubule and attenuates blood pressure responses in ANG II-induced hypertension. To determine the role of CAV-1 in mediating the uptake of FITC-labeled ANG II, wild-type (WT) mouse proximal convoluted tubule cells were transfected with CAV-1 small interfering (si)RNA for 48 h before AT1 receptor-mediated uptake of FITC-labeled ANG II was studied. CAV-1 siRNA knocked down CAV-1 expression by >90% (P < 0.01) and inhibited FITC-labeled ANG II uptake by >50% (P < 0.01). Moreover, CAV-1 siRNA attenuated ANG II-induced activation of MAPK ERK1/2 and Na(+)/H(+) exchanger 3 expression, respectively (P < 0.01). To determine whether CAV-1 regulates ANG II uptake in the proximal tubule, Alexa 488-labeled ANG II was infused into anesthetized WT and CAV-1 KO mice for 60 min (20 ng/min iv). Imaging analysis revealed that Alexa 488-labeled ANG II uptake was decreased by >50% in CAV-1 KO mice (P < 0.01). Furthermore, Val(5)-ANG II was infused into WT and CAV-1 KO mice for 2 wk (1.5 mg·kg(-1)·day(-1) ip). Basal systolic pressure was higher, whereas blood pressure and renal excretory and signaling responses to ANG II were attenuated, in CAV-1 KO mice (P < 0.01). We concluded that CAV-1 plays an important role in AT1 receptor-mediated uptake of ANG II in the proximal tubule and modulates blood pressure and renal responses to ANG II.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  angiotensin II; angiotensin II type 1a receptor; blood pressure; caveolin 1; kidney; proximal tubule; signal transduction

Mesh:

Substances:

Year:  2014        PMID: 25164083      PMCID: PMC4200294          DOI: 10.1152/ajprenal.00199.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  50 in total

1.  Strategy for the development of a matched set of transport-competent, angiotensin receptor-deficient proximal tubule cell lines.

Authors:  Philip G Woost; Robert J Kolb; Margaret Finesilver; Irene Mackraj; Hans Imboden; Thomas M Coffman; Ulrich Hopfer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

2.  Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand.

Authors:  L Hein; L Meinel; R E Pratt; V J Dzau; B K Kobilka
Journal:  Mol Endocrinol       Date:  1997-08

Review 3.  Localization and properties of angiotensin II receptors in rat kidney.

Authors:  J Zhuo; D Alcorn; P J Harris; F A Mendelsohn
Journal:  Kidney Int Suppl       Date:  1993-07       Impact factor: 10.545

Review 4.  The Caveolin genes: from cell biology to medicine.

Authors:  Terence M Williams; Michael P Lisanti
Journal:  Ann Med       Date:  2004       Impact factor: 4.709

5.  Basolateral distribution of caveolin-1 in the kidney. Absence from H+-atpase-coated endocytic vesicles in intercalated cells.

Authors:  S Breton; M P Lisanti; R Tyszkowski; M McLaughlin; D Brown
Journal:  J Histochem Cytochem       Date:  1998-02       Impact factor: 2.479

6.  Caveolin-1 is not essential for biosynthetic apical membrane transport.

Authors:  Aki Manninen; Paul Verkade; Soazig Le Lay; Juha Torkko; Michael Kasper; Joachim Füllekrug; Kai Simons
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  In vivo occupancy of angiotensin II subtype 1 receptors in rat renal medullary interstitial cells.

Authors:  J Zhuo; D Alcorn; J McCausland; D Casley; F A Mendelsohn
Journal:  Hypertension       Date:  1994-06       Impact factor: 10.190

8.  Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs.

Authors:  D S Majid; A Williams; L G Navar
Journal:  Am J Physiol       Date:  1993-01

9.  Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation.

Authors:  N Ishizaka; K K Griendling; B Lassègue; R W Alexander
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

10.  AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: role of cytoskeleton microtubules and tyrosine phosphatases.

Authors:  Xiao C Li; Oscar A Carretero; L Gabriel Navar; Jia L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-14
View more
  10 in total

Review 1.  The renal antioxidative effect of losartan involves heat shock protein 70 in proximal tubule cells.

Authors:  Patricia G Vallés; Victoria Bocanegra; Valeria V Costantino; Andrea F Gil Lorenzo; María Eugenia Benardon; Valeria Cacciamani
Journal:  Cell Stress Chaperones       Date:  2020-05-23       Impact factor: 3.667

Review 2.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

3.  Augmentation of angiotensinogen expression in the proximal tubule by intracellular angiotensin II via AT1a/MAPK/NF-кB signaling pathways.

Authors:  Jia L Zhuo; H Kobori; Xiao C Li; R Satou; A Katsurada; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-10

Review 4.  Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension.

Authors:  Qiang Li; Ji-Youn Youn; Hua Cai
Journal:  J Hypertens       Date:  2015-06       Impact factor: 4.844

Review 5.  The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.

Authors:  Beje Thomas; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 6.  Recent Updates on the Proximal Tubule Renin-Angiotensin System in Angiotensin II-Dependent Hypertension.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

7.  Suppression of angiotensin II-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide.

Authors:  Panneerselvam Chinnakkannu; Charles Reese; John Antony Gaspar; Saraswathi Panneerselvam; Dorea Pleasant-Jenkins; Rupak Mukherjee; Catalin Baicu; Elena Tourkina; Stanley Hoffman; Dhandapani Kuppuswamy
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

Review 8.  Intratubular, Intracellular, and Mitochondrial Angiotensin II/AT1 (AT1a) Receptor/NHE3 Signaling Plays a Critical Role in Angiotensin II-Induced Hypertension and Kidney Injury.

Authors:  Xiao Chun Li; Chih-Hong Wang; Ana Paula Oliveira Leite; Jia Long Zhuo
Journal:  Front Physiol       Date:  2021-08-02       Impact factor: 4.566

9.  Caveolin-1 Expression Ameliorates Nephrotic Damage in a Rabbit Model of Cholesterol-Induced Hypercholesterolemia.

Authors:  Ya-Hui Chen; Wei-Wen Lin; Chin-San Liu; Li-Sung Hsu; Yueh-Min Lin; Shih-Li Su
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

Review 10.  Role of Caveolin-1 in Diabetes and Its Complications.

Authors:  Dania Haddad; Ashraf Al Madhoun; Rasheeba Nizam; Fahd Al-Mulla
Journal:  Oxid Med Cell Longev       Date:  2020-01-27       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.